Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD

J.A. van Noord, Joseph Aumann, Jan Verhaert, +3

CHEST Journal

Pulmonary CirculationCardiovascular DiseaseAdvanced Lung DiseaseAirflow ObstructionWithout Formoterol +5

The efficacy of tiotropium administered via Respimat® Soft Mist™ Inhaler or HandiHaler® in COPD patients

J.A. van Noord, P. J. G. Cornelissen, Joseph Aumann, +3

Respiratory Medicine

Pulmonary CareAdvanced Lung DiseasePulmonary PharmacologyCopd PatientsPulmonary Medicine +3

Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms

J.A. van Noord, Joseph Aumann, J.J. Smeets, +3

Respiratory Medicine

AsthmaAdvanced Lung DiseaseAirflow ObstructionPulmonary MedicineMedicine +2

Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study

Walter Vincken, Joseph Aumann, Hungta Chen, +3

International Journal of COPD

Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

Kristina Vermeersch, Maria Gabrovska, Joseph Aumann, +22

American Journal of Respiratory and Critical Care Medicine

Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: A randomized, crossover study

Craig LaForce, Joseph Aumann, L. de Teresa Parreño, +5

Pulmonary Pharmacology & Therapeutics

Advanced Lung DiseaseDaily IndacaterolPulmonary PharmacologyPharmacotherapyCrossover Study +3

Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons

Revathy Munuswamy, Jana De Brandt, Chris Burtin, +4

Journal of Inflammation Research

The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Kristina Vermeersch, Maria Gabrovska, Griet Deslypere, +9

International Journal of COPD

Comparison Of 24-Hour FEV1 Profile For Once-Daily Versus Twice-Daily Treatment With Olodaterol, A Novel Long-Acting B2-Agonist, In Patients With COPD

Guy Joos, Joseph Aumann, Carl Coeck, +3

Pulmonary Care24-Hour Fev1 ProfilePulmonary MedicinePharmacotherapyMedicine +1

Carnosine, oxidative and carbonyl stress, antioxidants, and muscle fiber characteristics of quadriceps muscle of patients with COPD

Jana De Brandt, Chris Burtin, Pascal Pomiès, +10

Journal of Applied Physiology